Bin Meng M.D.,Ph.D.
Director

Degrees
M.D., Ph.D., Shantou University Medical College, Shantou, Guangdong Province

Major Previous Appointments
 Dr. Meng has focused his career on the diagnosis of surgical pathology for more than twenty years. He had worked as an associate professor and chief physician of pathology in the Department of Pathology, Shandong University School of Medicine from 2003 to 2013. From Jan. 2009 to Jan. 2010 he received one year training of Hamatopathology as a Visiting Scholar in the Department of Pathology and Microbiology, UNMC, Omaha, NE, USA. His expertise is the pathologic diagnosis of lymphoma and cancer molecular diagnosis, and he is also good at the pathologic diagnosis of tumors occurring in various organs and tissues such as thyroid, lung, GI, GYU, soft tissue and so on. 

Fields of Interests
Prof. Meng’s major research interest is on molecular mechanisms of the progressing, drug-resistant and relapse of lymphomas (focus on DLBCL), and the application of biomarkers in pathological diagnosis.

Five Major publications

1. Huang X*, Meng B*, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G,Delabie J, Campo E, Braziel RM, Gascoyne RD, Cook JR, Tubbs RR, Jaffe ES, Armitage JO, Vose JM, Staudt LM, McKeithan TW, Chan WC, Ye BH, Fu K. Activation of the STAT3 Signaling Pathway Is Associated With Poor Survival in Diffuse Large B-Cell Lymphoma Treated With R-CHOP. J Clin Oncol. 2013 Dec 20;31(36):4520-8. (Co-first authors)

2. Pan Y*, Meng B*, Zhang H, Cao W, Wang H, Bi C, Liu F, Sun B, Hao X, Ai WZ, Fu K. Low incidence of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China. Leuk Lymphoma. 2013;54(2): 298-303. (Co-first authors)

3. Bin MENG, Kai FU. Advances and Updates on pathological diagnosis of lymphoma . Chin J Clin Oncol. 2016;43(14):613-619

4. Yan LIANG, Yi PAN, Aiju FANG, Bingxin GUAN, Yingying HUO, Yan WANG, Baocun SUN, Kai FU, Bin MENG. An investigation of MYC gene aberration in diffuse large B-cell lymphomas. Chin J Clin Oncol. 2013;40(9):513-516

5. HUO Ying-ying, PAN Yi, GUAN Bing-xin, FANG Ai-ju, SUN Boo-cun, ZHOU Geng-yin, FU Kai, MENG Bin. Significance of MUM-l/IRF4 protein expression in follicular lymphoma. Chin J Pathol. 2011;40(8):528-531